Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
maurizio.inghilleri@uniroma1.it
Maurizio Inghilleri
Professore Associato
Struttura:
DIPARTIMENTO DI NEUROSCIENZE UMANE
E-mail:
maurizio.inghilleri@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Retrospective observational study on the use of acetyl-L-carnitine in ALS
JOURNAL OF NEUROLOGY
2023
Does Patisiran Reduce Ocular Transthyretin Synthesis? A Pilot Study of Two Cases
CURRENT NEUROPHARMACOLOGY
2023
Correction: Immune-mediated myogenesis and acetylcholine receptor clustering promote a slow disease progression in ALS mouse models
INFLAMMATION AND REGENERATION
2023
Withdrawal of mechanical ventilation in amyotrophic lateral sclerosis patients: a multicenter Italian survey
NEUROLOGICAL SCIENCES
2023
RNA Interference and Neuromuscular Diseases: A Focus on Hereditary Transthyretin Amyloidosis
CURRENT GENE THERAPY
2023
Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis?
EUROPEAN JOURNAL OF NEUROLOGY
2023
Genetics screening in an Italian cohort of patients with Amyotrophic Lateral Sclerosis: the importance of early testing and its implication
JOURNAL OF NEUROLOGY
2023
A novel homozygous mutation in TBK1 gene causing ALS-FTD
NEUROLOGICAL SCIENCES
2022
Paraneoplastic neuromyelitis optica spectrum disorder associated with lung adenocarcinoma: a case report
FRONTIERS IN MEDICINE
2022
Classical and Unexpected Effects of Ultra-Micronized {PEA} in Neuromuscular Function
BIOMOLECULES
2022
Effects of Skin Stimulation on Sensory-Motor Networks Excitability: Possible Implications for Physical Training in Amyotrophic Lateral Sclerosis
FRONTIERS IN NEUROLOGY
2022
The Silent Period for Small Fiber Sensory Neuropathy Assessment in a Mixed Cohort of Transthyretin-Mediated Amyloidosis
BIOMEDICINES
2022
Effects of 3,4-diaminopyridine on myasthenia gravis: Preliminary results of an open-label study
FRONTIERS IN PHARMACOLOGY
2022
Functional and morphometric assessment of small-fibre damage in late-onset hereditary transthyretin amyloidosis with polyneuropathy: the controversial relation between small-fibre-related symptoms and diagnostic test findings
AMYLOID
2022
Validation of the DYALS (dysphagia in amyotrophic lateral sclerosis) questionnaire for the evaluation of dysphagia in ALS patients
NEUROLOGICAL SCIENCES
2022
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial
EUROPEAN JOURNAL OF NEUROLOGY
2022
A longitudinal study defined circulating microRNAs as reliable biomarkers for disease prognosis and progression in ALS human patients
CELL DEATH DISCOVERY
2021
A case of acute motor and sensory axonal neuropathy mimicking brain death
NEUROLOGICAL SCIENCES
2021
Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension
NEUROLOGY
2021
The beneficial effect of physiotherapy on the cervical spine mobility of ACDF patients and healthy individuals: An original observational cohort comparison research protocol
INTERDISCIPLINARY NEUROSURGERY
2021
« prima
< precedente
1
2
3
4
5
6
seguente ›
ultima »
Gruppi di ricerca - Responsabile
Gruppo di ricerca sulla sclerosi laterale amiotrofica
Gruppo di ricerca sull'amiloidosi sistemica da transtiretina
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma